Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al

V F A M Derksen; L A Trouw; T W J Huizinga; A H M van der Helm-van Mil; R Knevel; H Westerlind; S Saevarsdottir; S Ajeganova; D van der Woude

doi:10.1002/art.40678

Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al

V F A M Derksen, L A Trouw, T W J Huizinga, A H M van der Helm-van Mil, R Knevel, H Westerlind, S Saevarsdottir, S Ajeganova, D van der Woude

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	2096-2097
Number of pages <span style="color:red"p> <font size="1.5"> ✽ </span> </font>	2
Journal	Arthritis & Rheumatology
Volume	70
Issue number	12
DOIs	https://doi.org/10.1002/art.40678
Publication status	Published - Dec 2018

Keywords

Rheumatoid Arthritis
Anti-Carbamylated Protein Antibodies

Access to Document

10.1002/art.40678

Cite this

Derksen, V. F. A. M., Trouw, L. A., Huizinga, T. W. J., van der Helm-van Mil, A. H. M., Knevel, R., Westerlind, H., Saevarsdottir, S., Ajeganova, S., & van der Woude, D. (2018). Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al. Arthritis & Rheumatology, 70(12), 2096-2097. https://doi.org/10.1002/art.40678

Derksen, V F A M ; Trouw, L A ; Huizinga, T W J ; van der Helm-van Mil, A H M ; Knevel, R ; Westerlind, H ; Saevarsdottir, S ; Ajeganova, S ; van der Woude, D. / Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts : Comment on the Article by Truchetet et al. In: Arthritis & Rheumatology. 2018 ; Vol. 70, No. 12. pp. 2096-2097.

@article{176a2fd250ef4901bfba7e9dd896abd0,

title = "Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al",

keywords = "Rheumatoid Arthritis, Anti-Carbamylated Protein Antibodies",

author = "Derksen, {V F A M} and Trouw, {L A} and Huizinga, {T W J} and {van der Helm-van Mil}, {A H M} and R Knevel and H Westerlind and S Saevarsdottir and S Ajeganova and {van der Woude}, D",

year = "2018",

month = dec,

doi = "10.1002/art.40678",

language = "English",

volume = "70",

pages = "2096--2097",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "John Wiley and Sons Inc.",

number = "12",

}

Derksen, VFAM, Trouw, LA, Huizinga, TWJ, van der Helm-van Mil, AHM, Knevel, R, Westerlind, H, Saevarsdottir, S, Ajeganova, S & van der Woude, D 2018, 'Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al', Arthritis & Rheumatology, vol. 70, no. 12, pp. 2096-2097. https://doi.org/10.1002/art.40678

Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts : Comment on the Article by Truchetet et al. / Derksen, V F A M; Trouw, L A; Huizinga, T W J; van der Helm-van Mil, A H M; Knevel, R; Westerlind, H; Saevarsdottir, S; Ajeganova, S; van der Woude, D.

In: Arthritis & Rheumatology, Vol. 70, No. 12, 12.2018, p. 2096-2097.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts

T2 - Comment on the Article by Truchetet et al

AU - Derksen, V F A M

AU - Trouw, L A

AU - Huizinga, T W J

AU - van der Helm-van Mil, A H M

AU - Knevel, R

AU - Westerlind, H

AU - Saevarsdottir, S

AU - Ajeganova, S

AU - van der Woude, D

PY - 2018/12

Y1 - 2018/12

KW - Rheumatoid Arthritis

KW - Anti-Carbamylated Protein Antibodies

UR - http://www.scopus.com/inward/record.url?scp=85055524760&partnerID=8YFLogxK

U2 - 10.1002/art.40678

DO - 10.1002/art.40678

M3 - Letter

C2 - 30058116

VL - 70

SP - 2096

EP - 2097

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5191

IS - 12

ER -

Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al

Keywords

Access to Document

Other files and links

Cite this